Statistical analysis of in vivo tumor growth experiments.

We review and compare statistical methods for the analysis of in vivo tumor growth experiments. The methods most commonly used are deficient in that they have either low power or misleading type I error rates. We propose a set of multivariate statistical modeling methods that correct these problems, illustrating their application with data from a study of the effect of alpha-difluoromethylornithine on growth of the BT-20 human breast tumor in nude mice. All the methods find significant differences between the alpha-difluoromethylornithine dose groups, but recommended sample sizes for a subsequent study are much smaller with the multivariate methods. We conclude that the multivariate methods are preferable and present guidelines for their use.

[1]  P. Diggle.  An approach to the analysis of repeated measurements. , 1988, Biometrics.

[2]  M D Schluchter,et al.  Methods for the analysis of informatively censored longitudinal data. , 1992, Statistics in medicine.

[3]  J. Koziol,et al.  A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. , 1981, Biometrics.

[4]  R. Little.  Models for Nonresponse in Sample Surveys , 1982 .

[5]  Mu‐Hsien Yu,et al.  Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinoma , 1992, International journal of cancer.

[6]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[7]  N M Laird,et al.  Missing data in longitudinal studies. , 1988, Statistics in medicine.

[8]  Noel A Cressie,et al.  A spatial statistical analysis of tumor growth , 1992 .

[9]  L. Demers,et al.  Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice. , 1992, Cancer letters.

[10]  D. Heitjan.  Generalized Norton-Simon models of tumour growth. , 1991, Statistics in medicine.

[11]  J. Lazo,et al.  In vivo circumvention of human colon carcinoma resistance to bleomycin. , 1992, Cancer research.

[12]  R. Fisher.  The Advanced Theory of Statistics , 1943, Nature.

[13]  E. Vonesh,et al.  Mixed-effects nonlinear regression for unbalanced repeated measures. , 1992, Biometrics.

[14]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[15]  D. F. Morrison,et al.  Multivariate Statistical Methods , 1968 .

[16]  J. Laissue,et al.  Pharmacologic interactions between the resistance‐modifying cyclosporine sdz psc 833 and etoposide (VP 16–213) enhance In Vivo cytostatic activity and toxicity , 1992, International journal of cancer.

[17]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[18]  V A Gor'kov,et al.  [Mathematical aspects of the kinetics of distribution, transformation and elimination of antineoplastic agents in the body]. , 1973, Izvestiia Akademii nauk SSSR. Seriia biologicheskaia.

[19]  Michael Stuart,et al.  Understanding Robust and Exploratory Data Analysis , 1984 .

[20]  Peter J. Diggle,et al.  Informative dropout in longitudinal data analysis. , 1994 .

[21]  B. Schem,et al.  Thermochemotherapy with cisplatin or carboplatin in the BT4 rat glioma in vitro and in vivo. , 1992, International journal of radiation oncology, biology, physics.

[22]  M. Kenward,et al.  Informative dropout in longitudinal data analysis (with discussion) , 1994 .

[23]  D. Heitjan,et al.  Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer. , 1991, Cancer Research.

[24]  M. Boyd,et al.  Evaluation of metastatic human tumor burden and response to therapy in a nude mouse xenograft model using a molecular probe for repetitive human DNA sequences. , 1992, Cancer research.

[25]  F. Martin,et al.  Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid , 1992, International journal of cancer.

[26]  J. Isaacs,et al.  The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers. , 1992, Cancer research.

[27]  K. Bailey,et al.  Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. , 1989, Biometrics.

[28]  P. P. Di Fiore,et al.  Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies. , 1992, Cancer research.

[29]  D. Hinkley,et al.  The Analysis of Transformed Data , 1984 .

[30]  R. Potthoff,et al.  A generalized multivariate analysis of variance model useful especially for growth curve problems , 1964 .

[31]  A. Schally,et al.  Effect of microcapsules of luteinizing hormone‐releasing hormone antagonist SB‐75 and somatostatin analog RC‐160 on endocrine status and tumor growth in the dunning R‐3327H rat prostate cancer model , 1992, The Prostate.

[32]  G. Reinsel,et al.  Models for Longitudinal Data with Random Effects and AR(1) Errors , 1989 .

[33]  D. Coulter,et al.  Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. , 1992, Cancer research.

[34]  Y. Maehara,et al.  Flavone acetic acid increases the antitumor effect of hyperthermia in mice. , 1992, Cancer research.

[35]  Gary O. Zerbe,et al.  Randomization Analysis of the Completely Randomized Design Extended to Growth and Response Curves , 1979 .

[36]  E. Vonesh,et al.  Efficient inference for random-coefficient growth curve models with unbalanced data. , 1987, Biometrics.

[37]  J. Lyons,et al.  Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. , 1992, Radiation research.

[38]  M. Landström,et al.  Effects of 6‐methylene progesterone on growth, morphology, and blood flow of the dunning R3327 prostatic adenocarcinoma , 1992, The Prostate.

[39]  K. Muller,et al.  Power Calculations for General Linear Multivariate Models Including Repeated Measures Applications. , 1992, Journal of the American Statistical Association.

[40]  A. Schally,et al.  Inhibition of growth of PC‐82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC‐3095 or combination of agonist [D‐Trp6]‐luteinizing hormone‐releasing hormone and somatostatin analog RC‐160 , 1992, The Prostate.

[41]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.